The concept of PLGA-lipid hybrid nanoparticles arose as a motivation for developing drug
delivery systems with versatile physical and chemical properties, unequivocal therapeutic …

The ability of chitosan (CTS) to promote mucoadhesion, trigger positive/negative surface
interactions, and open tight junctions has inspired researchers to coat lipid-based and …

This review provides a comprehensive and updated overview of the state of the art related to
the biomedical applications of nanoparticles coated with chitosan. Discussions were based …

Colloidal drug delivery systems have been extensively investigated as drug carriers for the
application of different drugs via different routes of administration. Systems, such as solid …

Drug delivery to the lungs by inhalation offers a targeted drug therapy for respiratory
diseases. However, the therapeutic efficacy of inhaled drugs is limited by their rapid …

Lung cancer has been recognized as one of the most often diagnosed and perhaps most
lethal cancer diseases worldwide. Conventional chemotherapy for lung cancer-related …

The advent of biodegradable polymer-encapsulated drug nanoparticles has made the
pulmonary route of administration an exciting area of drug delivery research. Chitosan, a …

Proteins and peptides are widely indicated in many diseased states. Parenteral route is the
most commonly em-ployed method of administration for therapeutic proteins and peptides …

To consider the lung as a target for drug delivery and to optimise strategies directed at the
pulmonary route, it is essential to consider the role of pulmonary surfactant, a thin lipid …

Due to their excellent in vitro activity against multidrug resistant bacteria, antimicrobial
peptides (AMPs) hold promise for treatment of Pseudomonas aeruginosa lung infections in …